Targeting chemoattractant chemokine (C-C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
FRONTIERS IN IMMUNOLOGY（2023）
摘要
Our results indicate that CCL2 may serve as a promising candidate target for inflammatory disorder therapy, including NMOSD.
更多查看译文
关键词
NMOSD,neuroinflammation,CCL2,monocyte,astrocyte
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要